Cross Country Healthcares, Inc (NASDAQ:CCRN)’s traded shares stood at 0.66 million during the latest session, with the company’s beta value hitting 0.60. At the last check today, the stock’s price was $18.10, to imply a decrease of -0.30% or -$0.06 in intraday trading. The CCRN share’s 52-week high remains $23.64, putting it -30.61% down since that peak but still an impressive 47.07% since price per share fell to its 52-week low of $9.58. The company has a valuation of $595.96M, with an average of 1.39 million shares in intraday trading volume over the past 10 days and average of 948.43K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Cross Country Healthcares, Inc (CCRN), translating to a mean rating of 2.75. Of 2 analyst(s) looking at the stock, 0 analyst(s) give CCRN a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cross Country Healthcares, Inc (NASDAQ:CCRN) trade information
After registering a -0.30% downside in the latest session, Cross Country Healthcares, Inc (CCRN) has traded red over the past five days. The 5-day price performance for the stock is 67.64%, and 58.12% over 30 days. With these gigs, the year-to-date price performance is -20.03%. Short interest in Cross Country Healthcares, Inc (NASDAQ:CCRN) saw shorts transact 2.84 million shares and set a 3.83 days time to cover.
The extremes give us $21 and $21 for target low and target high price respectively. As such, CCRN has been trading -16.02% off suggested target high and -16.02% from its likely low.
Cross Country Healthcares, Inc (CCRN) estimates and forecasts
Looking at statistics comparing Cross Country Healthcares, Inc share performance against respective industry, we note that the company has underperformed competitors. Cross Country Healthcares, Inc (CCRN) shares are 24.78% up over the last 6 months, with its year-to-date growth rate lower than industry average at -76.68% against -26.00%. The rating firms project that company’s revenue will shrink -33.59% compared to the previous financial year.
Revenue forecast for the current quarter as set by 8 analysts is 307.76M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 304.95M.Earnings reports from the last fiscal year show that sales brought in 414.04M and 379.17M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -25.67% before dropping -19.58% in the following quarter.
CCRN Dividends
Cross Country Healthcares, Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Cross Country Healthcares, Inc (NASDAQ:CCRN)’s Major holders
Cross Country Healthcares, Inc insiders hold 5.58% of total outstanding shares, with institutional holders owning 110.22% of the shares at 116.75% float percentage. In total, 110.22% institutions holds shares in the company, led by BLACKROCK INC. As of 2024-06-30, the company held over 5.92 million shares (or 17.4438% of shares), all amounting to roughly $81.99 million.
The next major institution holding the largest number of shares is PACER ADVISORS, INC. with 4.55 million shares, or about 13.4006% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $62.98 million.
